These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3149350)

  • 1. [Progress in clinical methods of complement system analysis and data interpretation].
    Inai S
    Nihon Rinsho; 1988 Sep; 46(9):2046-53. PubMed ID: 3149350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exploration of the route of complement activation in idiopathic membranoproliferative glomerulonephritis and lupic nephropathy].
    Gutiérrez Millet V; Prieto C; Ortuño MT; Usera G; Jarillo MD; Ruilope LM; Rodicio JL
    Rev Clin Esp; 1978 Nov; 151(3):223-8. PubMed ID: 740997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anomalies of the complement system in human nephropathies].
    Kourilsky O
    Cah Med; 1973 Jun; 14(6):389-97. PubMed ID: 4203255
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute lupus erythematosus with total absence of the C4 fraction of complement].
    Hauptmann G; Grosshans E; Heid E; Mayer S; Basset A
    Nouv Presse Med; 1974 Apr; 3(14):881-2. PubMed ID: 4601861
    [No Abstract]   [Full Text] [Related]  

  • 7. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ; Dixon FJ
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of hemolytic complement activity via classical pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():634-6. PubMed ID: 2355588
    [No Abstract]   [Full Text] [Related]  

  • 10. Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.
    Kohler PF; Ten Bensel R
    Clin Exp Immunol; 1969 Feb; 4(2):191-202. PubMed ID: 4978055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Process of complement activation in systemic lupus erythematosus and acute nephritis].
    Otani I
    Nihon Jinzo Gakkai Shi; 1976 Sep; 18(9):547-63. PubMed ID: 1034132
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complement: physiopathology, pharmacology and clinical aspects].
    Orrico A; Auteri A
    Ann Sclavo Collana Monogr; 1985; 2(1-2):3-146. PubMed ID: 3880494
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.
    Soothill JF
    Clin Exp Immunol; 1967 Jan; 2(1):83-92. PubMed ID: 4166187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of the complement system in nephropathies of childhood].
    Zelazko ME; Feldman G
    Medicina (B Aires); 1977; 37(3):205-14. PubMed ID: 895495
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complement activation of alternative pathway in renal diseases and systemic lupus erythematosus (author's transl)].
    Nakayama S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):447-61. PubMed ID: 529617
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical applications of complement assays.
    Alper CA; Rosen FS
    Adv Intern Med; 1975; 20():61-88. PubMed ID: 46689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Whole serum complement in kidney diseases and systemic lupus erythematosus].
    Stein G; Stelzner A; Tanner E
    Z Gesamte Inn Med; 1973 Aug; 28(16):469-76. PubMed ID: 4129087
    [No Abstract]   [Full Text] [Related]  

  • 20. Membranous glomerulopathy in systemic lupus erythematosus.
    Gonzalez-Dettoni H; Tron F
    Adv Nephrol Necker Hosp; 1985; 14():347-64. PubMed ID: 3919538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.